One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells
Triple-negative breast cancer (TNBC) is a highly aggressive malignancy with limited treatment options due to its heterogeneity and the lack of well-defined molecular targets. In our endeavour towards the development of novel anti-TNBC agents, herein we report a one-pot three-component synthesis of n...
Saved in:
Main Authors: | Wagdy M. Eldehna (Author), Dina H. EL-Naggar (Author), Ahmed R. Hamed (Author), Hany S. Ibrahim (Author), Hazem A. Ghabbour (Author), Hatem A. Abdel-Aziz (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents
by: Wagdy M. Eldehna, et al.
Published: (2017) -
Anticancer activity of Piper cubeba L. extract on triple negative breast cancer MDA-MB-231.
by: Saowanee Maungchanburi, et al.
Published: (2022) -
Mechanism for ginsenoside Rh2-induced apoptosis of triple-negative breast cancer MDA-MB-231 cells
by: Y. Zeng, et al.
Published: (2020) -
Cytotoxic properties, glycolytic effects and high-resolution respirometry mitochondrial activities of Eriocephalus racemosus against MDA-MB 231 triple-negative breast cancer
by: Francis Adu-Amankwaah, et al.
Published: (2024) -
Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell
by: Mingjiang Yao, et al.
Published: (2019)